TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0%
Tue, 28 Jan

TORRENT PHARMA has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m20,51020,05019,660-1.9%-4.1%
Other incomeRs m3034053055.9%1666.7%
TurnoverRs m20,54020,39020,190-1.0%-1.7%
ExpensesRs m14,90014,64014,260-2.6%-4.3%
Gross profitRs m5,6105,4105,400-0.2%-3.7%
DepreciationRs m1,5601,6301,6300.0%4.5%
InterestRs m1,3301,1601,110-4.3%-16.5%
Profit before taxRs m2,7502,9603,1907.8%16.0%
TaxRs m29052068030.8%134.5%
Profit after taxRs m2,4602,4402,5102.9%2.0%
Gross profit margin%27.427.027.5
Effective tax rate%10.517.621.3
Net profit margin%12.012.012.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 4.1% on a year-on-year (YoY) basis. The expenses were down by 4.3% YoY during the same period.
  • The company's operating profit declined by 3.7% YoY during the quarter. Consequently, operating profit margins remained same and stood at 27.5% in 3QFY20.
  • Depreciation charges increased by 4.5% and finance costs declined by 16.5% YoY, respectively.
  • Other income increased by 1666.7% YoY during the quarter.
  • Net profit for the quarter increased by 2.0% YoY. Net profit margins during the quarter increased from 12.0% in 3QFY19 to 12.4% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 1.9% on a quarter-on-quarter (QoQ) basis. The expenses were down by 2.6% QoQ during the same period.
  • The company's operating profit declined by 0.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.5% in 3QFY20 as against 27.0% in 2QFY19.
  • Net profit for the quarter increased by 2.9% QoQ, while net profit margins increased from 12.0% in 2QFY19 to 12.4% in 3QFY20.

To see how TORRENT PHARMA has performed over the last eight quarters,please visit here.

FREE TRANSCRIPT: See How Richa Picks Potentially Crorepati-Making Stocks...

TORRENT PHARMA Share Price Performance

Over the last one year,TORRENT PHARMA share price has moved up from Rs 1,848.2 to Rs 1,915.9, registering a Gain of Rs 67.7 or around 3.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,334.9 (up 0.2%). Over the last one year it has moved up from 13,658.2 to 14,334.9, a gain of 677 points (up 5.0%).

Overall, the S&P BSE SENSEX is up 15.2% over the year.

Current Valuations

At the current price of Rs 1,915.9, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 58.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.9 times.